Come join others currently navigating treatment in our weekly Virtual Support Groups! See times and register here.
AIs vs. Tamoxifen for Pre-Menopausal Women W/ Early-Stage, HR+
moderators
Posts: 9,652
Study Compares Aromatase Inhibitors vs. Tamoxifen for Pre-Menopausal Women With Early-Stage, Hormone Receptor-Positive Breast Cancer
December 15, 2021
Pre-menopausal women diagnosed with early-stage, hormone receptor-positive breast cancer who took an aromatase inhibitor along with ovarian suppression after surgery had a 3.2% lower risk of recurrence than women who took tamoxifen after surgery. Still, there was no difference in overall survival. Read more...
0
Categories
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your NEW profile.